query stringlengths 54 767 | positive stringlengths 1.02k 2k | negative stringlengths 1k 2k |
|---|---|---|
Agilent's test and measurement business targets high-growth wireless and Internet communications markets by providing test solutions ranging from under $1,000 to over $1 million for components, network equipment, and contract manufacturers. The company leverages collaborative relationships with major entities like Noki... | to be developed to enable testing of the new standards in the research and development and later in the manufacturing and deployment phases. We believe that in the last several years, producers of networking communications equipment have increased their use of contract manufacturers. Contract manufacturers require test... | e categorized as Level 3. A non-pricing service source prices certain privately placed corporate bonds using a model with observable inputs including, but not limited to, the credit rating, credit spreads, sector add-ons, and issuer specific add-ons. A non-pricing service source prices our CPI Caps using a model with i... |
The semiconductor products business generated $2.2 billion in revenue in fiscal year 2000, up from $1.7 billion in 1999 and $1.6 billion in 1998, employing approximately 10,200 people. The company serves the communications and computing markets, supplying components to major entities including Hewlett-Packard, Alcatel,... | rease. We believe that the principal factors of competition are: - speed, accuracy and cost of test; - breadth of product offerings; - scalability and flexibility of products; - ease of product use; - ability to upgrade product platform; - time to market of new technologies; - adherence to industry standards; - ability... | ibit access to care for enrollees. Subsequent regulations relevant to the EHB have continued the benchmark plan approach for 2016 and future years and have implemented clarifications and modifications to the existing EHB regulations, includin g the prohibition on discrimination, network adequacy standards and other req... |
Agilent has signed an agreement to sell its healthcare solutions business unit to Philips, a deal expected to close in the first half of 2001. The business unit, which reported $1.4 billion in revenue for fiscal year 2000, operates in over 100 countries and provides patient monitoring, ultrasound imaging, and cardiolog... | Stanley Electronic Co., Ltd., Infineon and Toshiba. HEALTHCARE SOLUTIONS Our healthcare solutions business is a worldwide leader in electro-medical clinical measurement and diagnostic solutions. Our products and systems enable medical professionals to gather and analyze information in hospital intensive care units and... | n the Chicago Divestiture. Excluding the gain, noninterest income increased $35 million driven by an accounting change for low-income housing investments, which is offset in income tax expense. Noninterest expense in 2015 of $94 million decreased $133 million from 2014, reflecting lower restructuring charges and specia... |
The company's chemical analysis business, which employed approximately 3,700 people as of October 31, 2000, generated $1.1 billion in revenue in fiscal year 2000, up from $1.0 billion in 1999 and $938 million in 1998. The company serves the hydrocarbon processing, environmental, and pharmaceutical markets, targeting a ... | et approval applications be submitted for our existing "Pre-Amendment" class III devices. Once clearance or approval is obtained, FDA oversight continues. We are required to demonstrate and maintain compliance with the Quality System Regulations for all our products. The FDA enforces the Quality System Regulations thro... | EX, are important to us and are generally covered by trademark applications or registrations in the USPTO and the patent or trademark offices of other countries. We also use trademarks licensed from third parties, such as the mark TYSABRI which we license from Elan. Trademark protection varies in accordance with local ... |
Agilent reported R&D expenditures of $1,258 million in fiscal year 2000, $997 million in 1999, and $948 million in 1998. International net revenue accounted for approximately 55.8% of total net revenue in fiscal year 2000, with Japan contributing roughly 19% of that international revenue. | ration, Thermo Electron, Inc. and Waters. Our ability to compete effectively depends upon a number of factors including our ability to: - produce high-quality and reliable products; - introduce new technologies and products in a timely manner; - provide favorable overall cost of ownership; and - provide product and ser... | . Accordingly, direct subsidiaries of Ares Management, L.P. that are treated as corporations for U.S. federal income tax purposes and that are the holders of Ares Operating Group Units are (and, in the case of Ares Offshore Holdings, Ltd., may be) subject to U.S. federal, state and local income taxes in respect of thei... |
The company operates 35 manufacturing sites and 196 million square feet of space worldwide, including headquarters in Palo Alto, California, and facilities in the U.S., China, Germany, Japan, Malaysia, Singapore, and the U.K. Key executives include Robert R. Walker as Executive Vice President and CFO, and Thomas A. Sap... | 43, has served as our Senior Vice President, Healthcare Solutions since October 1999. Prior to assuming that position, Mr. Rusckowski held a number of positions at Hewlett-Packard. He served as General Manager of the Cardiology Products Division from 1997 to 1999, General Manager of the Healthcare Information Manageme... | bligations. Any such failure would have a material adverse effect on the Company. Guarantees of indebtedness not recorded on the CompanyÂ’s consolidated balance sheets The following table summarizes the principal guarantees issued as of December 28, 2003 for which underlying liabilities are not recorded on the CompanyÂ’s... |
The company reported total net revenue of $10.8 billion in 2000, a 29.3% increase from 1999, driven by growth in the communications and electronics markets and increased demand in Asia. Net earnings rose to $757 million in 2000 from $512 million in 1999, while the company anticipates a $26 million cumulative after-tax ... | of our customers who often delay or accelerate purchases in reaction to variations in their businesses and in the economy. We expect some portions of our businesses to remain cyclical in the future. Given that a high proportion of our costs are fixed, variability in revenue as a result of these business cycles could di... | usiness with our existing business; • diversion of management resources and focus from ongoing business matters; • retention of key employees following the acquisition; • continued changes in the competitive environment, including recent announcements from competitors of new lower-priced scanners which we expect will l... |
The semiconductor products business reported net revenue of $2.213 billion and operating earnings of $270 million in 2000, driven by growth in networking and imaging components despite a 40.3% increase in SG&A expenses. Conversely, the healthcare solutions business saw net revenue decline 5.9% to $1.412 billion in 2000... | ed overall operating expenses higher. Research and development expenses increased 23.8 percent in 2000 compared to 1999 and were unchanged in 1999 compared to 1998. The increase in 2000 reflects increased activity in new product development in the communications market. Selling, general and administrative expenses incr... | the Indenture agreement. 52 Table of Contents On August 1, 2001 we completed the sale of our healthcare solutions business to Phillips for initial proceeds of approximately $1.7 billion. In May of 2002 we finalized the sale agreement. We received $1.6 billion in August of 2001 and since then we have received all of the... |
The company entered an agreement in Q1 2001 to sell its healthcare solutions business to Philips for approximately $1.7 billion and acquired OSI for $684 million in cash. It also plans to purchase the remaining 4.2% of Agilent Technologies Japan, Ltd's shares from Yokogawa by January 31, 2001, and anticipates selling i... | gies Japan, Ltd and several other companies. We expect to purchase the remaining 4.2% of Agilent Technologies Japan, Ltd's shares owned by Yokogawa prior to January 31, 2001. Hewlett-Packard provided the funding for the Yokogawa transaction in November 1999. Future sales of our portfolio of lease assets to CIT are anti... | Price and product competition in the communications and networking industries, which can change rapidly due to technological innovation and different business models from various geographic regions • The overall movement toward industry consolidation among both our competitors and our customers • The introduction and m... |
In the fourth quarter of 2000, Agilent entered into a vendor financing agreement with The CIT Group, Inc. to provide equipment financing through a new subsidiary, Agilent Financial Services, Inc., and sold a portion of its U.S. lease assets to CIT for net proceeds of $234 million. Additionally, Agilent reported net ear... | the purchase price was allocated to tangible assets. Dispositions. In the fourth quarter of 2000, Agilent entered into a vendor financing agreement with The CIT Group, Inc. (CIT), whereby CIT will provide equipment financing and leasing services to Agilent's customers on a global basis. Under the terms of the agreement... | sites, including three former MGP sites. The investigations have revealed contamination related to the by-products of gas manufacturing at each MGP site. In addition to the MGP sites, DTE Electric is also in the process of cleaning up other contaminated sites, including the area surrounding an ash landfill, electrical ... |
As of October 31, 2000, Agilent had 45,891,000 outstanding options with a weighted-average exercise price of $48, following the conversion of 17,667,000 Hewlett-Packard awards. Stock-based compensation expense for discounted options was $24 million in 2000, and pro forma adjustments for SFAS No. 123 would have reduced ... | ned in section 422 of the Internal Revenue Code, or non-statutory. Options generally vest at a rate of 25 percent per year over a period of four years from the date of grant. The exercise price for incentive stock options may not be less than 100 percent of the fair market value of the underlying Agilent stock on the d... | r value for these indemnification obligations was not material as of October 31, 2013 . Other Indemnifications As is customary in our industry and as provided for in local law in the U.S. and other jurisdictions, many of our standard contracts provide remedies to our customers and others with whom we enter into contrac... |
Following the June 2, 2000, distribution of Agilent shares to Hewlett-Packard shareholders, Agilent reported net revenue of $341 million from sales to Hewlett-Packard for the period from November 1, 1999, through June 2, 2000. The companies entered into various separation agreements, including a Master Separation and D... | ed health care trend rates could have a significant effect on the amounts reported for health care plans. A one-percentage point change in the assumed health care cost trend rates for the year ended October 31, 2000 would have the following effects: 1 PERCENTAGE 1 PERCENTAGE POINT INCREASE POINT DECREASE --------------... | internal Non-U.S. Fund distributors, to third party distributors of our non-U.S. Funds. Other compensation may be offered to the extent not prohibited by federal or state laws or any self-regulatory agency, such as the Financial Industry Regulatory Authority (“FINRA”). FTDI makes payments for events it deems appropriat... |
This exhibit index lists various agreements, including a Master Separation and Distribution Agreement, multiple technology and license agreements, and credit agreements between Hewlett-Packard and the Company. It also includes corporate documents such as the Certificate of Incorporation, Bylaws, and various employee st... | ------------------------------ Walter B. Hewlett /s/ HEIDI KUNZ Director January 14, 2001 ----------------------------------------------------- Heidi Kunz /s/ DAVID M. LAWRENCE Director January 14, 2001 ----------------------------------------------------- David M. Lawrence, M.D. Director ------------------------------... | NANCIAL CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 162 Capital One Financial Corporation (COF) Table of Contents CAPITAL ONE FINANCIAL CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 163 Capital One Financial Corporation (COF) Table of Contents CAPITAL ONE FINANCIAL CORPORATION NOTES TO CONSOLIDATED ... |
Agilent's test and measurement business provides automated test equipment and solutions for the wireless, semiconductor, and electronics industries, catering to original equipment manufacturers (OEMs), contract manufacturers (such as Solectron Corp. and Flextronics International), and service providers (including AT&T ... | eploy cellular base stations for these wireless networks. In addition, the rapid growth of the cellular handset market has created a new market segment for automated test equipment to test cellular handsets on the factory floor. Further, as new standards evolve in the wireless industry, new test and measurement equipme... | r executive officers. These key personnel have significant experience and skills in the homebuilding, lot development, financial services and rental housing industries, as well as leadership and management abilities that are vital to our success. Our ability to attract and retain our key personnel may be impacted by ma... |
The semiconductor products business reported revenues of $1.9 billion in fiscal year 2001, $2.2 billion in 2000, and $1.7 billion in 1999, employing approximately 9,000 people as of October 31, 2001. The company serves the networking, mobile communication, and computing/printing markets, acting as a leading supplier of... | for our large accounts, and enhance our understanding of the future needs of these customers. Our systems engineers provide a combination of consulting, systems integration and application and software engineering services, and are instrumental in all stages of the sale, implementation and support of our complex syste... | of the sector and maturity distributions, refer to Note 3 to the Consolidated Financial Statements under Item 8. Regulation Our insurance and reinsurance subsidiaries conduct business globally, including in all 50 states of the United States, the District of Columbia, and all U.S. Territories. Our business is subject t... |
The company provides analytical instrumentation for the chemical, environmental, pharmaceutical, and bioagriculture markets, offering products such as gas and liquid chromatographs and mass spectrometers. Its strategy focuses on targeting high-growth areas like gene expression and proteomics, expanding distribution in ... | tical instrumentation market. Primarily, our chemical analysis business serves the following markets: • chemical; • environmental; • pharmaceutical and biopharmaceutical; and • bioagriculture and foods. 14 Table of Contents Chemical Our chemical analysis business encompasses the natural gas, petroleum refining, petroch... | 8,264 19,638 1,217,902 Segment selling, general, administrative and development expense 51,666 16,438 68,104 4,351 72,455 Segment operating profit $ 964,539 $ 165,621 $ 1,130,160 $ 15,287 1,145,447 Other selling, general, administrative and development expense $ 107,919 107,919 Depreciation, amortization and accretion ... |
In fiscal year 2001, international net revenue accounted for approximately 59.8% of total net revenue, with Japan providing about 20% of that international portion, while long-lived assets outside the U.S. represented 43.7% of total long-lived assets. The company recorded approximately $459 million in inventory-related... | tive advantage. While we believe that our patents and applications have value, in general no single patent is in itself essential. In addition, we cannot assure you that any of our proprietary rights will not be challenged, invalidated or circumvented, or that our rights will provide significant competitive advantages.... | was proposed to transport onshore gas production from the Mackenzie Delta in northern Canada to established markets in North America. We have a 75 percent interest in the Parsons Lake natural gas field, one of the primary fields in the Mackenzie Delta, which would anchor the pipeline development. Due to a continued dec... |
The company reported an after-tax gain of $646 million from the sale of its healthcare solutions business to Philips, while also recognizing a $350 million restructuring charge to reduce its workforce by approximately 8,000 employees by mid-2002. Significant acquisitions during 1999-2001 included Objective Systems Inte... | lemented by the Amendment and Supplemental Agreement, dated as of August 1, 2001. The total purchase price is subject to adjustment based on the determination of the final purchased net assets and on our performance of certain services for Philips. Since August 1, 2001 we have received approximately $80 million of the ... | s based upon our operating results for each taxable jurisdiction in which we operate and the amount of statutory tax that we incur in each jurisdiction. We exercised significant judgment in regards to estimates of future market growth, forecasted earnings and projected taxable income, in determining the provision for i... |
The company's test and measurement business reported a 11.1% decrease in net revenue to $5,432 million in 2001 due to a slowdown in the telecommunications and semiconductor industries, resulting in an operating loss of $141 million. The semiconductor products business saw a 16.4% revenue decline to $1,850 million in 20... | tructuring charges. These items have been excluded for all periods presented. Test and Measurement Our test and measurement business provides test instruments, standard and customized test, measurement and monitoring instruments and systems for the design, manufacture and support of electronics and communications devic... | erson (and such person's affiliates and associates) that is the owner of 15% or more (a "15% Holder") of our outstanding voting shares) shall be required for various corporate actions, including: • merger or consolidation of the company into a 15% Holder; • sale of any or all of our assets to a 15% Holder; • the issuan... |
The company faces risks from inventory-related charges, such as the $459 million charge incurred in the year ended October 31, 2001, due to non-cancelable purchase commitments and declining demand. Additionally, the company faces operational risks from legacy system transitions, international trade volatility, and the ... | s could adversely affect our earnings. Our earnings could be harmed if we are unable to adjust our orders for parts to market fluctuations. In order to secure components for the production of products, we may enter into non-cancelable purchase commitments with vendors, or at times make advance payments to suppliers, wh... | the acquisition of Snyder’s-Lance. Total consideration was $6.112 billion , which included the payoff of approximately $1.1 billion of Snyder's-Lance indebtedness. We borrowed $900 million under a single draw 3-year senior unsecured term loan facility on March 26, 2018, and issued $5.3 billion senior notes on March 16,... |
Agilent Technologies, Inc. reported net earnings of $174 million for the fiscal year ended October 31, 2001, impacted by a $47 million net charge for adopting SAB 101 and a $25 million net charge for adopting SFAS No. 133. Key financial activities included the acquisition of Yokogawa's 4.2% interest in Agilent Technolo... | an, Ltd. shares from Yokogawa for approximately $216 million. In January 2001, Agilent completed its acquisition of YokogawaÂ’s 25 percent equity interest in Agilent Technologies Japan, Ltd. by purchasing the remaining 4.2 percent interest for approximately 60 Table of Contents AGILENT TECHNOLOGIES, INC. NOTES TO CONSOL... | Agilent's customers across a number of product lines and provide the same level of service and support expected from our direct channel. Lower dollar transactions can also be served by our tele-sales and electronic commerce channels. Our products typically come with three year standard warranties, and extended warranti... |
Agilent Technologies reported stock-based compensation expenses of $8 million in 2001, $24 million in 2000, and $39 million in 1999 (allocated from HP), while maintaining various plans including the Legacy Plan, the Agilent 423(b) Plan, and the 1999 Stock Plan. As of October 31, 2001, the company had 63,656,000 outstan... | years. After February 2, 2000, Agilent implemented the Agilent Technologies, Inc. Employee Stock Purchase Plan (the “Legacy Plan”) that was similar to the HP Plan and allowed eligible employees to contribute up to ten percent of their base compensation to the purchase of Agilent common stock. Under the provisions of t... | esponsibilities for compliance in reserves bookings to our Reserve Evaluation Group (the “Group”). These same policies also require that reserve estimates be made by professionally qualified reserves estimators, as defined by the Society of Petroleum Engineers’ standards. The Group, which is led by Devon’s Director of ... |
As of October 31, 2001, Agilent Technologies reported a net prepaid (accrued) cost of $(114) million for non-U.S. defined benefit plans and $107 million for U.S. defined benefit plans. The company also reported $169 million in non-current retirement benefit liabilities and maintained two revolving credit facilities tot... | ants’ contributions — — 8 7 4 5 Change in population estimate — 16 — 8 — 15 Benefits paid (41 ) (23 ) (10 ) (10 ) (11 ) (10 ) Currency impact — — (9 ) (87 ) — — Divestiture of Healthcare Solutions Business — — (60 ) — — — Other — — 14 — — — Fair value — end of year $ 451 $ 655 $ 746 $ 807 $ 311 $ 426 Change in benefit ... | c., effective as of August 12, 1999. S-1/A 11/10/1999 2.1 2.2 General Assignment and Assumption Agreement between Hewlett‑Packard and Agilent Technologies, Inc. S-1/A 11/10/1999 2.2 2.3 Master Technology Ownership and License Agreement between Hewlett‑Packard and Agilent Technologies, Inc. S-1/A 11/10/1999 2.3 2.4 Mast... |
For the fiscal year ended October 31, 2002, the company reported total net revenue of $6.0 billion, with the Test and Measurement segment contributing $3.3 billion (approximately 55% of total revenue). The company employed 36,000 people worldwide and maintained significant R&D and manufacturing sites across the U.S., C... | tronic commerce. Of our total net revenue of $6.0 billion in the fiscal year ended October 31, 2002, we generated 39 percent in the United States (“U.S.”) and 61 percent internationally. As of October 31, 2002, we employed approximately 36,000 people worldwide. We have major research and development (“R&D”) and manufac... | he various impacts of the Tax Act below. SEC Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (which we refer to as SAB 118) describes three scenarios associated with a company’s status of accounting for income tax reform. Under the SAB 118 guidance, we made reasonable ... |
The company provides a wide range of test and measurement solutions, including communication monitoring systems, general-purpose instruments, modular test software, and automated optical/x-ray/in-circuit inspection systems for electronics manufacturing. Key product offerings include semiconductor test equipment for fla... | mmission, and activate networks and services more quickly. For example, our 10-Gigabit Field Transmission Test Set enables technicians to test 192 fiber optic channels simultaneously. Also, our standards-based unification platform allows simplification of operation support and systems by reducing the software integrati... | es with low sales volumes, sales are made through various representatives and distributors. However, we also sell into international markets directly from the U.S. Our international business is subject to risks customarily encountered in foreign operations, including interruption to transportation flows for delivery of... |
The company produces a diverse range of semiconductor products, including DWDM optical transport ICs, RF/microwave communications (FBAR and E-pHEMT), and printer ASICs, with Hewlett-Packard accounting for approximately 33% of semiconductor revenue in fiscal year 2002. Additionally, the company operates a life sciences ... | are developing transmission and switching products for dense wave division multiplexing (“DWDM”) optical transport applications. High-Speed Digital Integrated Circuits. We produce physical layer ICs for high speed network switches and routers, devices that direct network traffic. We produce Fibre Channel protocol-based... | which the interest rate on a portion of this debt was effectively fixed through an interest rate swap agreement through the maturity of the swap in early June 2010. Concurrent with the maturity of the interest rate swap, we executed an interest rate cap limiting the maximum interest rate paid on the portion of the debt... |
Agilent expanded its life sciences and chemical analysis portfolio in 2002 by introducing products such as the 3000 Micro GC, the 1100 Series LC/MS system, and the Cerity Pharmaceutical Networked Data System. The company serves approximately 25,000 customers, with its top 25 customers accounting for approximately 22% o... | ns. For example, we have formed and expanded relationships with Incyte Genomics for microarray content and with Rosetta Inpharmatics, Inc. for microarray analysis software. In addition, we develop our products with a commitment to open platforms and industry standards in order to work with our partnersÂ’ products, enabl... | 11.5 15.4 10.6 Healthcare 12.0 11.8 14.1 10.9 Industrials 11.8 10.7 11.7 11.0 Consumer discretionary 9.4 10.7 8.3 10.6 Financial 8.5 13.4 11.7 16.1 Materials 5.7 3.5 5.2 3.7 Utilities 5.5 3.9 4.2 3.3 Telecomm services 3.9 3.2 3.5 3.1 Total 100.0 % 100.0 % 100.0 % 100.0 % Preferred Stocks We evaluate preferred stocks in... |
The company reported international net revenue of approximately 61% in fiscal 2002, with 11% of international revenue derived from Japan, while long-lived assets outside the U.S. accounted for approximately 62% of total long-lived assets in the same period. Significant historical acquisitions include Objective Systems ... | me custom work where it may be cost prohibitive to have multiple suppliers. Our long-term relationships with our suppliers allow us to proactively manage technology road maps and product discontinuance plans and monitor their financial health. Even so, some suppliers may still extend their lead times, limit supplies, i... | “Item 1. Business - Regulation and Legislation.” Various events could disrupt or result in unauthorized access to our networks, information systems or properties and could impair our operating activities and negatively impact our reputation and financial results. Network and information systems technologies are critica... |
Agilent Technologies reported a net loss of $1.032 billion for the fiscal year ended October 31, 2002, on net revenue of $6.010 billion, which included a $474 million pre-tax restructuring charge. The company is currently defending a securities class action (Kassin v. Agilent Technologies, Inc.) regarding its IPO and m... | offices throughout the world. Life Sciences and Chemical Analysis. Our life sciences and chemical analysis business has manufacturing facilities in California and Delaware in the U.S., China, Germany and Japan. We have marketing centers in Germany, Singapore and the U.S., and sales offices throughout the world. 26 Tabl... | to Exhibit (10) of our Form 8-K dated May 14, 2007. (iii) Increase of Commitments Agreement dated as of October 29, 2007 by and among Ecolab Inc., Citibank, N.A., JPMorgan Chase Bank, N.A., Credit Suisse, Cayman Islands Branch, National Association, Wells Fargo Bank, National Association, ABN AMRO Bank N.A., Bank of Am... |
The company reported a $1,607 million loss in 2002, down from a $778 million loss in 2001, as total net revenue fell 28% to $6,010 million due to weakness in the telecommunications and semiconductor markets. To mitigate these losses, the company implemented restructuring plans resulting in $880 million in savings and a... | 2001 and 2000. Gross proceeds from these dispositions were $31 million in 2002, $13 million in 2001 and insignificant in 2000. Gains from the dispositions, included in other income (expense), net, in the consolidated statement of operations, were $15 million in 2002, $9 million in 2001 and insignificant in 2000. Sale o... | ) Amortization of net prior service cost (benefit) $ — $ — $ (9 ) Amortization of actuarial net loss (gain) $ 3 $ 35 $ 11 Investment policies and strategies as of October 31, 2016 and 2015 . In the U.S., target asset allocations for our retirement and post-retirement benefit plans are approximately 80 percent to equiti... |
In 2002, the company reported a net revenue of $1,559 million and a loss from operations of $68 million, reflecting a 16% revenue decline from 2001 and a 62% improvement in operating margin. The company achieved approximately $600 million in savings from the 2001 Plan, including an 11% headcount reduction, while target... | ines or stagnation of the last several quarters, while reductions have been targeted to products in markets that are particularly weak and not expected to recover in the near term, such as wireline telecommunications. The increase in research and development expenses as a percentage of net revenue in 2001 compared to 2... | prices of these commodities could increase the costs of our products and services, and we may not be able to pass on these costs to our customers. We do not currently use financial derivatives to hedge against this volatility, however, we utilize firm purchase commitments to mitigate risk. The pricing of some commoditi... |
The company reported cash and cash equivalents of $1,844 million as of October 31, 2002, following a period of significant restructuring and cost-reduction measures that included $235 million in severance payments. Financial highlights include an after-tax gain of $646 million from the sale of its discontinued healthca... | eductions contributed approximately $20 million to our bottom line for the year. The increase in earnings from operations in 2001 compared to 2000 was primarily due to higher net 50 Table of Contents revenue and reduced spending resulting from our cost reduction measures. In addition, operational efficiencies arising o... | nts included in Part II, Item 8 — Financial Statements and Supplementary Data, included elsewhere in this report. During the year ended December 31, 2014 , the quality of the commercial loan portfolio improved. As of December 31, 2014 , total criticized loans decreased to 4.5% , or $1.9 billion , of the commercial loan... |
The company faces risks from excess manufacturing capacity, non-cancelable purchase commitments—which led to $459 million in inventory charges in 2001 and $40 million in 2002—and potential operational disruptions during the implementation of new enterprise resource planning software. Additionally, the company's results... | ich we compete. Each of the above measures could have long-term effects on our business by reducing our pool of technical talent, decreasing or slowing improvements in our products, making it more difficult for us to respond to customers, limiting our ability to increase production quickly if and when the demand for ou... | 6 versus 2005, and 2005 versus 2004. Years Ended October 31, 2006 over 2005 Change 2005 over 2004 Change 2006 2005 2004 Total gross margin 52 % 50 % 48 % 2 ppts 2 ppts Operating margin 15 % 14 % 14 % 1 ppt — Research and development $ 143 $ 136 $ 117 5% 16% Selling, general and administrative $ 430 $ 377 $ 342 14% 10% ... |
The company faces significant risks from non-compliance with complex international, federal, and state regulations regarding environmental protection, health and safety, and government contracts, where U.S. government sales account for approximately 5 percent of total sales. Additionally, the company faces potential li... | manufacturing processes involve the use of substances regulated under various international, federal, state and local laws governing the environment. We may be subject to liabilities for environmental contamination, and these liabilities may be substantial. Although our policy is to apply strict standards for environm... | ts. The increase in total cost of sales as a percentage of total net sales was primarily attributable to non-recurring expenses related to the Company's data migration to a new cloud-storage provider. Cost of product and service sales was $97.7 million and $69.2 million for the years ended December 31, 2016 and 2015, r... |
Agilent Technologies, Inc. reported a net loss of $1,032 million for the fiscal year ended October 31, 2002, and disclosed significant accounting adjustments including a $47 million net charge for SAB 101 adoption and a $25 million after-tax reduction for SFAS No. 133. The company also reported total property, plant, a... | ur customers on a global basis. This agreement has been in place since the fourth quarter of 2000. In addition to the CIT Group Sale and the sale of the healthcare solutions business, we sold assets related to portions of our businesses to third parties during 2002, 2001, and 2000. Gross proceeds from these disposition... | o AndroGel and Creon, to AbbVie's portfolio. Generic competition began in November 2012 for TriCor and is expected to begin in the second half of 2013 for Niaspan and in the second half of 2013 or early 2014 for TRILIPIX. As a result, sales for AbbVie's combined lipid franchise including TriCor, TRILIPIX, Niaspan and S... |
Agilent Technologies, Inc. reported total restructuring and asset impairment charges of $474 million for the year ended October 31, 2002, driven by the 2001 Plan ($511 million in cumulative expenses through October 31, 2002) and the 2002 Plan, which aimed to reduce quarterly operational costs by $50 million. Key activi... | e are exiting office space housing sales and administrative employees. However, a small number of production facilities were closed as a result of our plans to consolidate manufacturing into fewer sites. Asset impairment charges relate to fixed assets and were determined using estimates of the expected future cash flow... | marily on final assembly and test of our products. To maximize our productivity and our ability to respond to market conditions, we use contract manufacturers for the production of printed circuit boards, sheet metal fabrication, metal die-casting, plastic molding and standard electronic components. We also manufacture... |
Agilent Technologies reported total net plan costs of $105 million for 2002, driven by U.S. pension and post-retirement benefit costs of $99 million and non-U.S. costs of $6 million. As of October 31, 2002, the fair value of U.S. plan assets was $407 million against a benefit obligation of $761 million, while non-U.S. ... | g lifetime or total number of participants in our retirement and postretirement plans. The restructuring program and the sale of our healthcare solutions business described above both resulted in material changes to our plan demographics in the U.S. and several other countries. The curtailment and settlement gains and ... | r existing businesses in communications, life sciences, and electronics, and 2) research that creates new businesses that are outside of our current markets but within our fields of interest. Agilent Labs also provides technology integration across our company. 20 Table of Contents Index to Financial Statements Agilent... |
Agilent Technologies reported total net revenue of $6,010 million for the fiscal year ended October 31, 2002, with a reported loss from continuing operations before taxes of $1,547 million. The company operates three reportable segments—Test and Measurement, Semiconductor Products, and Life Sciences and Chemical Analys... | us to pay property taxes, insurance and routine maintenance, and include escalation clauses. Rent expense was $177 million in 2002, $100 million in 2001 and $69 million in 2000. 19. Contingencies We are involved in lawsuits, claims, investigations and proceedings, including patent, commercial and environmental matters ... | Our solutions for public companies include transactional and compliance reporting services to public companies, including document composition, SEC filing services for capital markets transactions such as initial public offerings, spin-offs, acquisitions, and debt and equity securities offerings, and year-round SEC dis... |
Agilent's test and measurement business, which employed approximately 11,900 people as of October 31, 2003, generated revenue of $2.5 billion in fiscal 2003, $2.6 billion in fiscal 2002, and $4.5 billion in fiscal 2001. The segment serves customers in over 110 countries providing solutions for communications test and g... | ures include items sold to contract manufacturers who manufacture products on Hewlett-PackardÂ’s behalf. Test and Measurement Our test and measurement business provides standard and customized solutions that are used in the design, development, manufacture, installation, deployment and operation of electronic equipment ... | jury coverage development, offset by strengthening in our homeowners lines. Auto liability claims process changes implemented in prior years, including a program requiring enhanced documentation of injuries and related medical treatments, resulted in favorable severity trends compared to those originally estimated as w... |
Agilent's automated test business, which employed approximately 2,300 people as of October 31, 2003, generated $0.8 billion in revenue in fiscal 2003, up from $0.7 billion in fiscal 2002 and $0.9 billion in fiscal 2001. The company utilizes a direct sales force of field and systems engineers, alongside value-added rese... | omer satisfaction. Our direct sales force is focused on identifying customer needs and recommending solutions involving the effective use and deployment of our equipment, services, systems and capabilities. Some members of our direct sales force focus on global accounts, providing uniform services on a worldwide basis.... | of Directors and the stockholders, respectively, approved the reservation of an additional 25 million shares of common stock under the 2018 Plan. The 2018 Plan provides for awards of stock-based incentive compensation to our employees (including officers) and directors. The 2018 Plan provides for the grant of awards in... |
The company is a leading supplier of fiber optic transceivers, high-speed digital ICs (including Fibre Channel controllers), and RF/microwave products like FBAR duplexers and E-pHEMT power amplifiers for networking and mobile systems. It also provides printing ASICs for Hewlett-Packard, infrared products, and is a join... | 1 Table of Contents Index to Financial Statements driven by the ongoing growth of data traffic. Business-to-consumer and business-to-business e-commerce, the internet, the growing volume of e-mail traffic, the growth of streaming video and audio, the delivery of online services, and peer-to-peer communications are all ... | f service may retire early from age 55 to 64. An early retirement factor is applied resulting in a reduced benefit. If an employee terminates with less than 5 years of service, such employee forfeits the right to receive any pension benefits accumulated to that time. Annual funding requirements are determined based on ... |
Agilent Technologies provides gas/liquid chromatography and mass spectrometry solutions for the petrochemical, homeland security, and life sciences markets, including the launch of the 6820 GC for China and the 1100 Series LC/MSD Trap XCT. The company also offers microarray and microfluidics solutions, notably the 2100... | , the industrial and manufacturing sectors, engineering and consulting companies, commercial testing laboratories and colleges and universities. We are seeing increased international demand for environmental instrumentation in the Asia-Pacific region. Petrochemical. The natural gas and petroleum refining markets use ou... | g ending the production of track drills; pursuing strategic alternatives, including the possible divestiture of room and pillar products; consolidation of two product development divisions; and additional actions in response to ongoing weakness in the mining industry. We estimate restructuring costs incurred under thes... |
Agilent Labs employs approximately 300 people, 70% of whom are technical staff with advanced degrees. The company reported R&D expenditures of $1,051 million in 2003, $1,250 million in 2002, and $1,358 million in 2001, while international net revenue accounted for approximately 64% of total net revenue in fiscal 2003. | r existing businesses in communications, life sciences, and electronics, and 2) research that creates new businesses that are outside of our current markets but within our fields of interest. Agilent Labs also provides technology integration across our company. 20 Table of Contents Index to Financial Statements Agilent... | ame line item as the offsetting loss or gain on the hedged item in the Consolidated Statements of Operations. Additionally, the Duke Energy RegistrantsÂ’ enter into derivative agreements that are economic hedges that either do not qualify for hedge accounting or have not been designated as a hedge. The changes in fair v... |
The company implemented a multi-year restructuring strategy (2001, 2002, and 2003 Plans) to reduce costs, resulting in $526 million in total charges through October 31, 2003, and an estimated quarterly savings of $350 million. Key actions included reducing the workforce by over 10,900 employees, consolidating more than... | 9,000 employees. Our plans to consolidate excess facilities resulted in charges for lease termination fees and losses anticipated from sub-lease agreements. We have exited, or plan to exit in the near future, more than 110 production, support and sales facilities in the U.S., Korea, Japan, U.K. and other countries, rep... | other employee stock plans 4 5 8 Diluted weighted average shares 345 353 355 The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense, the tax benefits or shortfalls ch... |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 52